Corcept Therapeutics
CORT
#1898
Rank
ยฃ6.08 B
Marketcap
ยฃ57.70
Share price
-6.20%
Change (1 day)
184.58%
Change (1 year)

P/E ratio for Corcept Therapeutics (CORT)

P/E ratio as of April 2025 (TTM): 84.1

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 84.1023. At the end of 2022 the company had a P/E ratio of 21.4.

P/E ratio history for Corcept Therapeutics from 2004 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202221.44.74%
202120.4-28.21%
202028.495.05%
201914.6-29.07%
201820.628.6%
201716.0-84.63%
2016104-246.14%
2015-71.1635.14%
2014-9.6838.68%
2013-6.98100.08%
2012-3.49-59.21%
2011-8.55-13.61%
2010-9.9035.29%
2009-7.32208.41%
2008-2.37-73.9%
2007-9.09705.38%
2006-1.13-72.79%
2005-4.15-40.94%
2004-7.02

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
11.0-86.93%๐Ÿ‡บ๐Ÿ‡ธ USA
13.9-83.41%๐Ÿ‡บ๐Ÿ‡ธ USA
28.6-66.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
138 63.94%๐Ÿ‡บ๐Ÿ‡ธ USA
12.5-85.14%๐Ÿ‡บ๐Ÿ‡ธ USA
44.7-46.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.4309-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-25.2-129.91%๐Ÿ‡บ๐Ÿ‡ธ USA
79.6-5.36%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.